Related by context. All words. (Click for frequent words.) 74 febrile neutropenia 74 virologic failure 73 ribavirin therapy 73 recurrent VTE 72 4mg/kg 72 leukopenia 72 Neutropenia 71 leucopenia 71 hypophosphatemia 71 hematologic toxicity 71 biochemical relapse 71 Thrombocytopenia 71 octreotide LAR 71 lopinavir r arm 71 receiving VICTRELIS 71 nadolol 71 receiving INTRON 71 tumor lysis syndrome 71 ipsilateral stroke 70 HBeAg negative 70 TEAEs 70 8mg/kg 70 adriamycin 70 flutamide 70 recurrent glioblastoma multiforme 70 cytopenias 70 SGPT 70 Doxil ® 70 evaluable subjects 70 neutropenia dehydration dyspnea 70 pT3 70 ALT flares 70 EXJADE 70 HBeAg seroconversion 70 severe hypersensitivity reactions 70 mg kg dose 70 mcg BID 69 alfa 2a 69 Infusion Reactions Severe 69 CMV infection 69 nephrotoxicity 69 pheochromocytoma 69 fluvastatin 69 APTIVUS r 69 neutrophil counts 69 thromboembolic events 69 â ‰ ¥ 69 hypomagnesemia 69 metastatic malignant 69 hepatorenal syndrome 69 generalized edema 69 Febrile neutropenia 69 Cutaneous T 69 prolonged QT interval 69 rizatriptan 69 rFVIIa 69 aspartate aminotransferase 69 adjunctive placebo 69 REYATAZ r arm 69 ribavirin RBV 69 clodronate 69 dasatinib Sprycel ® 69 PegIFN RBV 69 leukemia AML 68 saline placebo 68 achieved ACR# 68 FOLFOX4 alone 68 neutropaenia 68 interferon alfa 2a 68 severe oral mucositis 68 ADPKD 68 Hypotension 68 mg/m2 dose 68 metastatic GIST 68 cyclophosphamide methotrexate 68 hypercalcemia 68 abacavir lamivudine 68 definite stent thrombosis 68 pyrazinamide 68 FluCAM arm 68 trimethoprim sulfamethoxazole 68 candidemia 68 mcg QD 68 renal dysfunction 68 alanine aminotransferase 68 spinal cord compression 68 acute GvHD 68 myelosuppression 68 chemoradiation therapy 68 lymphocytosis 68 corticosteroid therapy 68 mycophenolate mofetil 68 aspartate aminotransferase AST 68 Peginterferon Alfa 2a 68 endometrial hyperplasia 68 insulin detemir 68 leukocytosis 68 docetaxel Taxotere ® 68 hemorrhagic cystitis 68 anthracycline taxane 68 PREZISTA r 68 mcg kg REBETOL 68 elevated ALT 68 HBeAg negative patients 68 HBeAg positive 68 advanced adenoma 68 concomitant medications 68 chlorambucil 68 endophthalmitis 68 aplastic anemia AA 67 aminotransferase elevations greater 67 Pemetrexed 67 colorectal carcinoma 67 Toxicities 67 dalteparin 67 Asymptomatic 67 HBeAg positive patients 67 mg QD 67 ritonavir boosted 67 Pegylated Liposomal Doxorubicin 67 Peg IFN 67 virologic response 67 pyelonephritis 67 chronic GVHD 67 antiretroviral naive 67 BARACLUDE ® 67 q#h 67 cisplatin chemotherapy 67 complement inhibitor eculizumab 67 peripheral sensory neuropathy 67 VELCADE melphalan 67 lymphopenia 67 neutropenic fever 67 Chronic Hepatitis C 67 adjunctive ABILIFY 67 FOLFOX4 67 piperacillin tazobactam 67 invasive aspergillosis 67 thrombocytopenic 67 periprocedural 67 Ribavirin causes 67 mg m² 67 hypokalemia 67 FOLFIRI alone 67 gout flares 67 thromboembolic complications 67 docetaxel chemotherapy 67 colorectal adenoma 67 plus gemcitabine 67 anterior uveitis 67 stage IIIb IV 67 reinfarction 67 elevated transaminases 67 TNF antagonist 67 moderate renal impairment 67 virologic breakthrough 67 receiving prophylactic anticoagulation 67 #mg BID [001] 67 intracranial hemorrhage ICH 67 metastatic malignant melanoma 67 discontinuations due 67 MGd 67 metastatic carcinoid tumors 67 Renal impairment 67 hemorrhagic complications 67 voriconazole 67 weekly subcutaneous injections 67 hypersensitivity reaction 67 imipenem 67 log# copies mL 67 unresectable HCC 67 relapsed MM 67 Pegylated Interferon 67 IIIa inhibitor 67 #mg/m# [002] 67 neutrophil count 67 renal insufficiency 67 p = NS 67 Postoperative complications 67 alpha interferons 66 antithymocyte globulin 66 anaphylactoid reactions 66 mcg mL 66 FOLFOX6 66 thrombocytopenia 66 posaconazole 66 amoxicillin clavulanate 66 bone marrow suppression 66 NovoLog ® Mix 66 receiving VELCADE 66 deep venous thromboses 66 pCR 66 intravitreal injections 66 oral antidiabetic medication 66 urate lowering therapy 66 mycophenolic acid 66 thromboembolic 66 non squamous NSCLC 66 pancytopenia 66 neutropenic patients 66 5-FU/LV 66 Folfox 66 interferon alfa 66 % CI #.#-#.# [003] 66 K ras mutations 66 CMV disease 66 androgen deprivation 66 β blocker 66 liver decompensation 66 moderately emetogenic 66 autoantibody positive 66 % CI #.#-#.# [007] 66 pyrexia mucositis sepsis febrile 66 NOLVADEX 66 recurrent UTI 66 recurrent genital herpes 66 β blockers 66 arterial thromboembolic events 66 anemia hemoglobin 66 ALT elevation 66 severe exacerbations 66 Flu Cy 66 transaminase elevations 66 gastrointestinal perforation 66 invasive candidiasis 66 cells uL 66 PEG IFN 66 mild renal insufficiency 66 anagrelide 66 mRCC 66 mg BID 66 TMP SMX 66 Pred Forte 66 severe renal impairment 66 Leukemias 66 5 Fluorouracil 66 MULTAQ 66 TO AVOID PREGNANCY WHILE 66 NATRECOR R 66 treatment naive genotype 66 certolizumab 66 ertapenem 66 Diffuse Large B 66 baseline LDH 66 FOLFIRI 66 PREZISTA r arm 66 grade cervical intraepithelial 66 hepatitis C genotype 66 dexamethasone Decadron 66 serum aminotransferase levels 66 heparin induced thrombocytopenia 66 symptomatic VTE 66 #mg/m# [001] 66 Myelodysplastic Syndrome MDS 66 ALT normalization 66 neoadjuvant 66 hydroxymethyl coenzyme 66 log# reduction 66 haematological toxicity 66 virological response 66 amphotericin B 66 ara C 66 haematologic 66 HCV genotype 66 rFSH 66 hematologic abnormalities 66 daunorubicin 66 P = .# 66 peginterferon 66 ANCA associated 66 seropositive patients 66 NATRECOR ® 66 argatroban 66 interferon ribavirin 66 ZYVOX 66 myelodysplastic myeloproliferative diseases 66 interferon alfa 2b 66 ug dose 66 thrombocytopenia neutropenia 66 PSA nadir 66 DOXIL 66 highly emetogenic 66 Pegylated 66 sulfasalazine 66 TRAIL R1 66 esophagitis 66 lenalidomide Revlimid R 66 postoperative chemotherapy 66 chronic eosinophilic leukemia 66 hepatotoxicity 65 SUVmax 65 IIIa inhibitors 65 metastatic neuroendocrine tumors 65 Lactic acidosis 65 PEGINTRON TM 65 PegIFN 65 Severe Sepsis 65 efalizumab 65 thrombocytosis 65 COPD exacerbation 65 valsartan amlodipine 65 mg TID 65 Paraplatin ® 65 anemia neutropenia 65 lactic acidosis 65 Known hypersensitivity 65 stage IIIB 65 CANCIDAS 65 tirofiban 65 ATACAND 65 p = #.# [003] 65 ARCOXIA 65 Angioedema 65 hyperphenylalaninemia HPA due 65 Natalizumab 65 mg/m2/day 65 induce orthostatic hypotension 65 serum prostate 65 intravenous bisphosphonates 65 MACCE 65 plus dexamethasone 65 cidofovir 65 asthma exacerbation 65 Peginterferon 65 biologic DMARD 65 Metastatic Prostate Cancer 65 dapagliflozin plus 65 microgram kg 65 progression TTP 65 invasive carcinomas 65 IV NSCLC 65 paclitaxel cisplatin 65 vWD 65 x ULN 65 Erythropoietic therapies may 65 Nebulized 65 mCi kg 65 Pegasys plus Copegus 65 placebo dexamethasone 65 prior chemotherapy regimens 65 salmeterol fluticasone 65 PREZISTA rtv 65 chemotherapy induced neutropenia 65 peginterferon alfa 65 comparator arm 65 postoperative complication 65 tumor xenograft models 65 serum phosphate 65 mg ustekinumab 65 DLTs 65 IFN α 65 papillary renal cell carcinoma 65 estramustine 65 peripheral edema 65 recurrent NSCLC 65 cisplatin gemcitabine 65 tipranavir r 65 SPRYCEL ® 65 Lupus nephritis 65 GISTs 65 activated partial thromboplastin 65 5 FU leucovorin 65 Myelosuppression 65 palifermin 65 EBRT 65 essential thrombocythemia 65 alteplase 65 #mg BID [003] 65 HSCT 65 XIENCE V PROMUS Stent 65 PRADAXA #mg 65 Adefovir 65 Platinol ® 65 interferon therapy 65 Hormone Refractory Prostate Cancer 65 Nilotinib 65 mcg kg 65 alanine aminotransferase ALT 65 oral allopurinol 65 pneumonectomy 65 severe hypoglycemic 65 mcg albinterferon alfa 2b 65 serum creatinine levels 65 chronic HCV infection 65 graft occlusion 65 subtrochanteric 65 bacteriuria 65 HCV Genotype 65 macroalbuminuria 65 binary restenosis 65 intramuscularly 65 GnRH agonist 65 rebleeding 65 log# IU mL 65 mg/m2 IV 65 mycophenolate 65 steroid dexamethasone 65 DAPT 65 μmol L 65 ancrod 65 CC genotype 65 MCyR 65 detectable HCV RNA 65 intravenous bolus 65 Follicular Lymphoma 65 posttransplant 65 basiliximab 65 pT2 65 anthracyclines taxanes 65 PAOD 65 adenomatous polyps 65 lymphoid blast 65 small lymphocytic lymphoma 65 Pharmacokinetics PK 65 CR nPR 65 dacarbazine DTIC 65 neutropenia 65 VT VF 65 cetuximab Erbitux R 65 CIMZIA TM 65 colorectal liver metastases 65 transurethral resection 65 receiving ISENTRESS 65 endometrial carcinoma 65 mCi 65 gemcitabine carboplatin 65 virological failure 65 genotypic resistance 65 intravesical therapy 65 myalgia arthralgia 65 lopinavir r 65 virologic failures 65 FASLODEX 65 neutropenia thrombocytopenia 64 symptomatic hypotension 64 #Gy 64 Oral Fingolimod 64 dosage regimens 64 cis retinoic acid 64 rapid virologic response 64 fluorouracil leucovorin 64 ALT elevations 64 nonfatal MI 64 tolvaptan 64 homozygous familial hypercholesterolemia 64 % AST SGOT 64 partial remissions 64 ovarian carcinoma 64 atrophic gastritis 64 herpes zoster shingles 64 hypereosinophilic syndrome 64 tenecteplase 64 receiving XGEVA 64 pericardial effusion 64 torsade de pointes 64 Unstable Angina 64 hematologic adverse 64 fibrinolysis 64 #mg/day [002] 64 MYLOTARG 64 Sezary syndrome 64 q8h 64 MYCAMINE 64 low dose cytarabine 64 Infusion reactions 64 doxorubicin cyclophosphamide 64 fluorouracil 64 antiandrogen 64 pericardial effusions 64 basal cell carcinoma BCC 64 TORISEL 64 Naive Patients 64 paroxysmal AF 64 sorafenib Nexavar 64 nephrotoxic drugs 64 aminotransferases 64 gastric adenocarcinoma 64 erlotinib Tarceva ® 64 5-fluorouracil/leucovorin 64 ABC/3TC 64 cGy 64 thrombotic events 64 FOLPI 64 locoregional 64 hepatic failure 64 unstable angina pectoris 64 underlying vasculopathy 64 mg q#h 64 budesonide pMDI 64 symptomatic hypoglycemia 64 Soft Tissue Sarcoma 64 metastatic RCC 64 decitabine 64 cells μL 64 Telintra 64 CrCl 64 Elitek 64 ethambutol 64 gemcitabine Gemzar 64 mitoxantrone plus 64 Recurrences 64 cilengitide 64 HCV genotypes 64 cabazitaxel 64 mucosal inflammation 64 hepatic enzymes 64 refractory NSCLC 64 acarbose 64 plus methotrexate 64 ug kg 64 incidence ≥ 64 CIMZIA TM certolizumab pegol 64 cerebrovascular events 64 mitoxantrone chemotherapy 64 CsA 64 isoproterenol 64 mitoxantrone 64 antiretroviral naïve 64 Mg Usa 64 atazanavir ritonavir 64 benazepril 64 QT QTc 64 idarubicin 64 MALT lymphoma 64 infusional 64 ACTEMRA TM 64 allogeneic hematopoietic stem cell 64 danazol 64 PEGylated Fab fragment 64 fallopian tube cancers 64 serum potassium 64 leukemia ALL 64 indinavir 64 overt nephropathy 64 potent CYP#A# inhibitors 64 HIV RNA 64 daily subcutaneous injections 64 IU ml 64 perioperatively 64 elevated LDH 64 concomitant antibiotics 64 PSADT 64 Decitabine 64 adrenalectomy 64 underwent resection 64 ABRAXANE therapy 64 nicardipine 64 CLL SLL 64 doxazosin 64 TAXUS p value 64 myelofibrosis polycythemia vera 64 tolterodine ER 64 pamidronate 64 bolus dose 64 Stomatitis 64 cell lymphoma CTCL 64 ventricular tachycardia VT 64 KRAS mutant tumors 64 QTc prolongation 64 Pegylated interferon 64 weekly intravenous infusions 64 hepatic metastases 64 hypertrichosis occurred 64 Index CDAI 64 Hodgkin lymphoma HL 64 pegylated interferon alpha 64 oral vancomycin 64 Myelodysplastic Syndrome 64 QTc interval 64 macrovascular events 64 serum calcium levels 64 CHOP chemotherapy 64 REMICADE monotherapy 64 methotrexate monotherapy 64 nadroparin 64 receiving immunosuppressive therapy 64 nonmetastatic 64 esophageal candidiasis 64 paragangliomas 64 liver histology 64 hemoptysis 64 unresectable tumors 64 prednisone prednisolone 64 gefitinib Iressa 64 INCB# [003] 64 sustained virologic response 64 fallopian tube carcinoma 64 neutropenic 64 myeloablative 64 mucosal healing 64 Refractory Hodgkin Lymphoma 64 delayed CINV 64 seropositivity 64 μg dose 64 symptomatic intracranial hemorrhage 64 androgen suppression 64 leukocyte count 64 MADRS score 64 CMV seropositive 64 T2DM 64 angiotensin converting enzyme inhibitor 64 CCyR 64 tamsulosin 64 mL/min/#.# m 2 64 hallucinations dyskinesia 64 tenofovir emtricitabine 64 pegylated interferon alfa 2b 64 TAXOTERE R 64 ischemia driven 64 hypoglycemic events 64 taxane chemotherapy 64 KRAS mutations occur 64 lichen planus 64 corrected QT interval 64 events AEs 64 6 mercaptopurine 64 q#d 64 FOLFOX 64 hepatocellular carcinomas 64 Patients Receiving 64 azathioprine 64 PEGylated anti 64 proctitis 64 baseline neutrophil counts 64 lupus erythematosus 64 olmesartan 64 novel VDA molecule 64 PREZISTA ritonavir 64 neurologic progression 64 paricalcitol 64 streptokinase 63 NRTI resistance 63 B7 H3 63 thrombophlebitis 63 demonstrated antitumor activity 63 Platinol ® cisplatin 63 Amgen Neulasta R 63 Myelofibrosis 63 nephrotoxic 63 pegylated liposomal doxorubicin 63 NYHA Class II 63 Monotherapy 63 fluticasone salmeterol 63 nelfinavir 63 Randomized Phase 63 stable angina 63 cytogenetic abnormalities 63 insulin glulisine 63 glycated hemoglobin levels 63 Relapsed Refractory Multiple Myeloma 63 cholelithiasis 63 serum HCV RNA 63 complete cytogenetic response 63 interleukin IL -# 63 leukoencephalopathy 63 mg BID dose 63 systemic corticosteroids 63 CIMZIA ™ 63 nortriptyline Pamelor 63 achieved CCyR 63 Retreatment 63 Neulasta ® 63 plasma uric acid 63 pathologic fracture 63 plus GP IIb 63 nevirapine Viramune 63 DFMO 63 pegIFN 63 glulisine 63 malignancy HCM 63 liposomal amphotericin B 63 5FU 63 Ranolazine 63 advanced adenomas 63 FUSILEV enhances 63 histologically confirmed 63 Xelox 63 serum ALT 63 distant metastasis 63 AST ALT 63 hypoperfusion 63 HGPIN 63 pouchitis 63 graft dysfunction 63 telaprevir dosed 63 EURIDIS 63 Mg Uk 63 intravenous tissue plasminogen 63 ULORIC 63 BENICAR HCT 63 refractory chronic lymphocytic 63 transplantation HCT 63 tumor recurrence 63 Median PFS 63 receiving highly emetogenic 63 confidence interval #.#-#.# 63 locoregional recurrence 63 FEMALES SHOULD BE ADVISED 63 doxorubicin docetaxel 63 renal toxicity 63 adalimumab Humira 63 ≥ Grade 63 renal cell carcinomas 63 hyperkalemia 63 #mg QD [001] 63 splenectomized patients 63 Castration Resistant Prostate Cancer 63 TURBT 63 elotuzumab 63 liver metastasis 63 adefovir 63 oral Hycamtin 63 serum urate 63 systemic corticosteroid 63 sunitinib Sutent ® 63 pooled comparator 63 % Confidence Interval 63 necrotizing pancreatitis 63 Cyclophosphamide 63 fatigue asthenia 63 VFEND 63 serum urate levels 63 RLAI 63 total thyroidectomy 63 pleural effusion 63 TIMP 1 63 angioneurotic edema 63 Antitumor Activity 63 HBsAg 63 clopidogrel Plavix 63 ZOMETA 63 AZT zidovudine Retrovir 63 unfractionated heparin UFH 63 PEGASYS ® 63 Vidaza ® 63 K#N 63 mitomycin 63 BEACOPP 63 CCR5 tropic HIV 63 intra articular injection 63 Host Disease 63 oxycodone CR 63 del 5q MDS 63 administered subcutaneously 63 Serious adverse reactions 63 Dasatinib 63 cardiac toxicity 63 allogeneic bone marrow 63 mg qd 63 cisplatin vinorelbine 63 recurrent DVT 63 dacarbazine 63 tipranavir 63 HCV genotype 1 63 immunomodulatory therapy 63 adjuvant radiation 63 NPH insulin 63 variceal hemorrhage 63 TP# mutations 63 Relapsing Remitting Multiple Sclerosis 63 postoperative AF 63 carboplatin paclitaxel 63 pulmonary exacerbations 63 μg mL 63 myocardial infarction ventricular fibrillation 63 confidence interval CI 63 haloperidol Haldol 63 R# #mg BID 63 nonischemic 63 Patients Treated With 63 serum HBV DNA 63 hepatectomy 63 MAGE A3 ASCI 63 dose cytarabine 63 immune thrombocytopenic purpura ITP 63 non splenectomized 63 nucleoside naive 63 Ischemic 63 PROSTVAC VF 63 nitazoxanide 63 Acute myeloid leukemia 63 beclomethasone dipropionate 63 creatinine clearance 63 hypoglycemic episodes 63 hepatocellular carcinoma HCC 63 #.#mg/dL 63 dose cohort 63 Kepivance 63 COPEGUS 63 Malignant Melanoma 63 gastrointestinal stromal tumors GIST 63 lymphocyte counts 63 cardiogenic shock 63 Relapsed Refractory 63 fatigue diarrhea nausea 63 relapsed SCLC 63 mm3 63 adrenal suppression 63 ceftazidime 63 cilostazol 63 node metastases 63 idiopathic PAH 63 recurrent wheezing 63 Pioglitazone 63 nab paclitaxel 63 Helicobacter pylori eradication 63 immune globulin intravenous 63 microg 63 #mg QD [002] 63 elevated serum creatinine 63 dysuria 63 mg eq 63 infliximab monotherapy 63 autoimmune hemolytic anemia 63 platinum refractory 63 gastrointestinal toxicities 63 leiomyomas 63 Q2W 63 aminotransferase levels 63 elevated creatinine 63 CIN3 63 amprenavir 63 esophageal carcinoma 63 Interferon Beta 63 squamous 63 pancreatic carcinoma 63 Complicated Skin 63 recurrent venous thromboembolism 63 metastatic renal cell carcinoma 63 LHRH agonists 63 Hypokalemia 63 neurologic complications 63 thrombotic thrombocytopenic purpura TTP 63 oral rivaroxaban 63 INVEGA ® 63 Forodesine HCl 63 headache abdominal pain 63 statin monotherapy 63 emtricitabine tenofovir 63 plus glycoprotein IIb 63 alkylating agent 63 urine cytology 63 Neovascular Age Related Macular 63 tigecycline 63 events SAEs 63 Capecitabine 63 severe hepatomegaly 63 gemcitabine cisplatin 63 Albuferon TM 63 solifenacin 63 salmeterol HFA MDI 63 mg/# hr 63 serum phosphorous 63 interstitial pneumonitis 63 thymoma 63 infusional 5-FU/LV 63 events TEAEs 63 Bezielle 63 transaminase 63 mcg doses 63 smoldering multiple myeloma 63 receiving golimumab 63 SGOT 63 Venous thromboembolism 63 Stent thrombosis 63 underwent surgical resection 63 biochemical recurrence 63 mucositis 63 mucocutaneous reactions 63 seminoma 63 leukemia CLL 63 remission CR 63 lupus nephritis 63 purpura ITP 63 lumbar spine BMD 63 mcg dose 63 relapsed refractory multiple myeloma 63 Allogeneic 63 cytoreduction 63 dermatologic toxicities 63 hypoglycaemic episodes 63 postoperative morbidity 63 Fludarabine 63 Renal dysfunction 63 neoadjuvant therapy 63 Hypersensitivity reactions 63 tipranavir ritonavir 63 ergot derivatives 63 allogeneic HSCT 63 primidone 63 Non inferiority 63 PEGylated interferon beta 1a 63 TPV r 63 oblimersen 63 bone marrow reticulin deposition 62 aspirin clopidogrel 62 pegylated interferon alfa 2a 62 specific antigen PSA 62 gastrointestinal stromal tumor 62 CYT# potent vascular disrupting 62 allogeneic stem cell 62 invasive ductal 62 thromboembolism 62 azacitidine 62 GLIADEL R Wafer 62 euthyroid 62 neovascular 62 Lenalidomide 62 platelet reactivity 62 bronchial hyperresponsiveness 62 Orally administered 62 coinfected 62 peginterferon alfa 2b 62 morphometric vertebral fractures 62 LOVENOX R 62 fosamprenavir 62 PASI scores 62 Adjuvant chemotherapy 62 debulking surgery 62 lactate dehydrogenase LDH 62 TELINTRA 62 TDF FTC 62 orally administered inhibitor 62 zolmitriptan 62 lispro 62 enalapril 62 malignant neoplasm 62 bexarotene 62 colorectal adenocarcinoma 62 Neoadjuvant 62 Anaphylactic reactions 62 μg ml 62 nephrectomy 62 CR CRu 62 IXEMPRA 62 histological subtype 62 pretransplant 62 UGT#A# * 62 preoperative chemotherapy 62 mEq L 62 myopathy rhabdomyolysis 62 cutaneous T 62 beta blocker therapy 62 pheochromocytomas 62 radiotherapy RT 62 Adenomas 62 ceftriaxone 62 null responders 62 Disease Progression 62 huN# DM1 62 keloid scarring 62 squamous histology 62 DETROL LA 62 humanized interleukin 6 62 Mitomycin C 62 superficial bladder cancer 62 lactate dehydrogenase 62 rt PA 62 bleomycin 62 neutropenic sepsis 62 Adjunctive 62 extrapyramidal symptoms 62 chemoembolization 62 NMIBC 62 vincristine doxorubicin 62 dose dexamethasone 62 Virologic 62 antibody titer 62 postprocedure 62 aprepitant 62 candesartan cilexetil 62 vWF 62 headache nasopharyngitis 62 ximelagatran 62 acromegalic patients 62 cytogenetic responses 62 immunosuppressive agents 62 AVODART 62 COPEGUS R 62 pelvic lymphadenectomy 62 timepoints 62 dosing cohorts 62 arterial thromboembolic 62 desvenlafaxine succinate 62 HBeAg 62 vasospasm 62 R0 resection 62 anthracycline containing 62 idraparinux 62 plus OBT 62 azathioprine monotherapy 62 imatinib resistant 62 HPA axis suppression 62 lenalidomide dexamethasone 62 PRADAXA 62 contrast induced nephropathy 62 Cell Lymphoma 62 surgical debulking 62 adenomatous